News Cochlear Limited

Stocks

COH

AU000000COH5

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 11:40:04 16/07/2026 am IST			5-day change	1st Jan Change
123.27 ^AUD	-0.59%		-1.24%	-52.71%

13/07	Cochlear Limited Announces FDA Clearance of The Osia 3 Sound Processor	CI
25/06	From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis	RE

All News

Mentions Relevance

13/07	Cochlear Limited Announces FDA Clearance of The Osia 3 Sound Processor	CI
04/05	From airlines to banks: Australian, New Zealand firms feel heat of Gulf crisis	RE
30/04	Cochlear Needs to Keep Promoting Implants as Volume Delays Not Structural, Says Jefferies, Shares Up 4%	MT
23/04	Jarden Adjusts Cochlear's Price Target to AU$169 from AU$224, Keeps at Neutral	MT
22/04	Cochlear Limited, Q3 2026 Sales/ Trading Statement Call, Apr 22, 2026
22/04	Australian shares close at two-week low, Cochlear crashes 41%	RE
22/04	Cochlear's Guidance Cut 'Far Worse Than Anticipated,' Multiple Also at Risk, Jarden Says	MT
22/04	Cochlear reduces underlying net profit guidance for FY26 to A$290-330 million	RE
22/04	Australia's Cochlear crashes 40% after flagging weak demand and Mideast war impact	RE
22/04	Cochlear Says Trading Conditions for Implants Weaker Than Expected Since January; Shares Hit 10-Year Low	MT
22/04	Cochlear cuts fiscal 2026 earnings outlook on Middle East-led demand uncertainty	RE
10/04	Cochlear Says Bank of New York Mellon Becomes Substantial Holder	MT
18/03	Cochlear : Hearing Loss Screening Fact Sheet	PU
17/03	Cochlear Poised for Medium-Term Growth on Nexa Launch, Jefferies Says	MT
13/02	Cochlear shares plunge, flags annual earnings at lower end of outlook	RE
13/02	Cochlear Limited, H1 2026 Earnings Call, Feb 13, 2026
13/02	Cochlear flags annual earnings at lower end of outlook, shares tank 16%	RE
13/02	Cochlear Fiscal H1 Earnings Slip, Total Revenue Flat; Shares Hit Over Three-Year Low	MT
13/02	Cochlear Fiscal H1 Earnings Slip, Total Revenue Flat	MT
13/02	Cochlear Posts Fiscal H1 Underlying EPS of AU$2.978, Sales Revenue of AU$1.18 Billion Vs FactSet Estimate of AU$1.21 Billion	MT
13/02	Cochlear posts H1 adjusted net income A$194.8 million	RE
13/02	Cochlear Limited Announces an Interim Franked Ordinary Dividend for the Six Months Ended December 31, 2025, Payable on 13 April 2026	CI
13/02	Cochlear Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
03/02	Cochlear Expected to Grow Market Share With Implant, Processor Products, Jefferies Says	MT
08/01	Cochlear Announces Availability of Nucleus Nexa System to Us Military Veterans	CI